The RESELECT Trial – REscuing bone marrow function in patients with relapsed aplaStic anaEmia and/or bone marrow failure post aLlogeneic stEm Cell Transplantation.
2020-2023 (Program): The RESELECT Trial – REscuing bone marrow function in patients with relapsed aplaStic anaEmia and/or bone marrow failure post aLlogeneic stEm Cell Transplantation. PI – Professor David Ritchie.
Related Projects
Evaluating Multidisciplinary Bone Marrow Failure Syndrome Care – a prospective observational clinical trial offering comprehensive diagnostic genomic evaluation, multidisciplinary case review and multidisciplinary clinical care
2019-2021 (Grant): Evaluating Multidisciplinary Bone Marrow Failure Syndrome Care – a prospective observational clinical trial offering comprehensive diagnostic genomic evaluation, multidisciplinary case review and multidisciplinary ...
Read moreDissecting immune dysregulation in acquired bone marrow failure syndromes to identify new therapeutic leads.
2022-2024 (Fellowship): Dissecting immune dysregulation in acquired bone marrow failure syndromes to identify new therapeutic leads. Dr Rachel Koldej, ACRF Translational Research Laboratory, Melbourne Health.
Read morePrecision gene editing for the treatment of Fanconi Anaemia.
2021-2023 (GIA): Precision gene editing for the treatment of Fanconi Anaemia. Dr Lorna McLeman, St Vincent’s Institute of Medical Research.
Read moreExtension to The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry
2019-2020 (Grant): Extension to The Australian Aplastic Anaemia and other Bone Marrow Failure Syndromes Registry (see above). Professor Erica Wood, Monash University Department of Epidemiology and Preventative Medicine. For further information, ...
Read more